$GINKO

EQT is reportedly resuming the sale of its contact lens manufacturer, Ginko, with expectations of generating at least $1 billion from the deal. This move highlights the growing interest in the eye care market, especially as consumers increasingly prioritize vision health. Analysts view this divestment as a strategic shift for EQT to focus on more lucrative investments. The potential acquisition could attract interest from larger healthcare companies looking to expand their portfolios. Overall, this development may signal a stronger market position for companies involved in healthcare and consumer goods.